Education
About Us
Working with TipRanks
Follow Us
RenovoRx (RNXT)
NASDAQ:RNXT
Total Valuation
RenovoRx has a market cap or net worth of $45.44M. The enterprise value is $36.04M.
Market Cap$45.44M
Enterprise Value$36.04M
Share Statistics
RenovoRx has 36,645,885 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding36,645,885
Owned by Insiders3.32%
Owned by Institutions16.95%
Financial Efficiency
RenovoRx’s return on equity (ROE) is -1.97 and return on invested capital (ROIC) is -173.00%.
Return on Equity (ROE)-1.97
Return on Assets (ROA)-1.09
Return on Invested Capital (ROIC)-173.00%
Return on Capital Employed (ROCE)-1.77
Revenue Per Employee4.30K
Profits Per Employee-881.40K
Employee Count10
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of RenovoRx is ―. RenovoRx’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value6.80
Price to FCF―
Price to Operating Cash Flow-3.36
PEG Ratio―
Income Statement
In the last 12 months, RenovoRx had revenue of 43.00K and earned -8.81M in profits. Earnings per share was -0.37.
Revenue43.00K
Gross Profit43.00K
Operating Income-10.97M
Pretax Income-8.81M
Net Income-8.81M
EBITDA-10.97M
Earnings Per Share (EPS)-0.37
Cash Flow
In the last 12 months, operating cash flow was -10.31M and capital expenditures -14.00K, giving a free cash flow of -10.32M billion.
Operating Cash Flow-10.31M
Free Cash Flow-10.32M
Free Cash Flow per Share-0.28
Dividends & Yields
RenovoRx pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.20
52-Week Price Change14.81%
50-Day Moving Average1.18
200-Day Moving Average1.17
Relative Strength Index (RSI)60.69
Average Volume (3m)303.15K
Important Dates
RenovoRx upcoming earnings date is Nov 17, 2025, After Close (Confirmed).
Last Earnings DateAug 14, 2025
Next Earnings DateNov 17, 2025
Ex-Dividend Date―
Financial Position
RenovoRx as a current ratio of 4.10, with Debt / Equity ratio of 2.44%
Current Ratio4.10
Quick Ratio4.10
Debt to Market Cap<0.01
Net Debt to EBITDA0.63
Interest Coverage Ratio0.00
Taxes
In the past 12 months, RenovoRx has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
RenovoRx EV to EBITDA ratio is -2.15, with an EV/FCF ratio of -2.58.
EV to Sales548.27
EV to EBITDA-2.15
EV to Free Cash Flow-2.58
EV to Operating Cash Flow-2.58
Balance Sheet
RenovoRx has $12.31M in cash and marketable securities with $260.00K in debt, giving a net cash position of -$12.05M billion.
Cash & Marketable Securities$12.31M
Total Debt$260.00K
Net Cash-$12.05M
Net Cash Per Share-$0.33
Tangible Book Value Per Share$0.19
Margins
Gross margin is 62.84%, with operating margin of -25511.63%, and net profit margin of -20497.67%.
Gross Margin62.84%
Operating Margin-25511.63%
Pretax Margin-20497.67%
Net Profit Margin-20497.67%
EBITDA Margin-25511.63%
EBIT Margin-25511.63%
Analyst Forecast
The average price target for RenovoRx is $3.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$3.50
Price Target Upside182.26% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast38.12%